• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达卡巴嗪在四肢黑色素瘤区域灌注中的药代动力学。

Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanoma.

作者信息

Didolkar M S, Jackson A J, Lesko L J, Fitzpatrick J L, Buda B S, Johnston G S, Zech L A

机构信息

Department of Surgery, Sinai Hospital, Baltimore, MD 21215, USA.

出版信息

J Surg Oncol. 1996 Nov;63(3):148-58. doi: 10.1002/(SICI)1096-9098(199611)63:3<148::AID-JSO4>3.0.CO;2-D.

DOI:10.1002/(SICI)1096-9098(199611)63:3<148::AID-JSO4>3.0.CO;2-D
PMID:8944058
Abstract

BACKGROUND

The pharmacokinetics of dacarbazine (DTIC), which has been shown to be an effective therapeutic agent against metastatic melanoma, has not been extensively studied. However, to improve the clinical use of the drug, more information on the kinetics is required.

METHODS

A pharmacokinetic study was undertaken in six patients with melanoma of an extremity who were undergoing hyperthermic isolation perfusion with DTIC in order to understand better its clinical pharmacokinetics. Plasma was sampled from the arterial and venous lines of an extracorporeal pump during the perfusion with the systemic vein and urine sampled postperfusion. Samples were analyzed for DTIC. 2-azahypoxanthine (2-AZA), and aminoimidazole carboxamide (AIC). 99(m)Tc (Technetium) human serum albumin (HSA) was used in the perfusion circuit to monitor the crossover of the perfusate into the systemic circulation during the procedure. The data were analyzed using a compartmental model of sampled body compartments incorporating the isolated extremity.

RESULTS

High tissue DTIC levels were maintained throughout the perfusion, whereas in the systemic circulation, plasma DTIC concentrations, when observed, were 40-100-fold less than those in the perfusate. Almost 70% of the DTIC administered was not recovered in the perfusate after the washout of the extremity.

CONCLUSIONS

High levels of DTIC can be maintained in an extremity (i.e., arm or leg) during perfusion.

摘要

背景

达卡巴嗪(DTIC)已被证明是一种治疗转移性黑色素瘤的有效药物,但其药代动力学尚未得到广泛研究。然而,为了改善该药物的临床应用,需要更多关于其动力学的信息。

方法

对6例肢体黑色素瘤患者进行了一项药代动力学研究,这些患者正在接受DTIC热隔离灌注,以便更好地了解其临床药代动力学。在通过体循环静脉进行灌注期间,从体外泵的动脉和静脉管路采集血浆,并在灌注后采集尿液。对样本进行DTIC、2-氮杂次黄嘌呤(2-AZA)和氨基咪唑甲酰胺(AIC)分析。在灌注回路中使用99(m)锝(Tc)人血清白蛋白(HSA)来监测灌注液在手术过程中进入体循环的情况。使用包含隔离肢体的采样身体隔室的房室模型对数据进行分析。

结果

在整个灌注过程中,组织中的DTIC水平保持较高,而在体循环中,观察到的血浆DTIC浓度比灌注液中的浓度低40-100倍。在肢体冲洗后,灌注液中未回收近70%给予的DTIC。

结论

在灌注过程中,DTIC可以在肢体(即手臂或腿部)中维持高浓度。

相似文献

1
Pharmacokinetics of dacarbazine in the regional perfusion of extremities with melanoma.达卡巴嗪在四肢黑色素瘤区域灌注中的药代动力学。
J Surg Oncol. 1996 Nov;63(3):148-58. doi: 10.1002/(SICI)1096-9098(199611)63:3<148::AID-JSO4>3.0.CO;2-D.
2
[New modifications in isolated extremity perfusion ].
Z Hautkr. 1982 Jul 15;57(14):1044-54.
3
Isolated extremity perfusion with DTIC. An experimental and clinical study.氮烯咪胺隔离肢体灌注:一项实验与临床研究。
Anticancer Res. 1983 Mar-Apr;3(2):87-93.
4
Toxicity and complications of vascular isolation and hyperthermic perfusion with imidazole carboxamide (DTIC) in melanoma.
Cancer. 1986 May 15;57(10):1961-6. doi: 10.1002/1097-0142(19860515)57:10<1961::aid-cncr2820571013>3.0.co;2-o.
5
Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique.黑色素瘤孤立肢体热灌注期间美法仑的监测:药代动力学研究及99mTc-白蛋白微胶体技术
Anticancer Res. 2001 May-Jun;21(3C):2243-8.
6
Regional isolated perfusion of high risk melanoma of the extremities with imidazole carboxamide.用咪唑甲酰胺对肢体高危黑色素瘤进行区域隔离灌注。
Surg Gynecol Obstet. 1984 Mar;158(3):238-42.
7
Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedules.达卡巴嗪(DTIC)及其代谢产物5-氨基咪唑-4-甲酰胺(AIC)在不同给药方案后的药代动力学。
Cancer Chemother Pharmacol. 1982;9(2):103-9. doi: 10.1007/BF00265388.
8
Influence of therapy on the antioxidant status in patients with melanoma.治疗对黑色素瘤患者抗氧化状态的影响。
J Clin Pharm Ther. 2008 Apr;33(2):179-85. doi: 10.1111/j.1365-2710.2008.00909.x.
9
Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.基于达卡巴嗪的转移性黑色素瘤化疗:三十年经验概述。
J Exp Clin Cancer Res. 2000 Mar;19(1):21-34.
10
Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients.黑色素瘤患者使用白细胞介素-2后达卡巴嗪药代动力学的改变。
Cancer Chemother Pharmacol. 1990;27(2):157-60. doi: 10.1007/BF00689102.

引用本文的文献

1
In vitro circuit stability of 5-fluorouracil and oxaliplatin in support of hyperthermic isolated hepatic perfusion.5-氟尿嘧啶和奥沙利铂在体外循环中的稳定性,以支持热灌注隔离肝灌注。
J Extra Corpor Technol. 2010 Mar;42(1):75-9.